Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1894 (LINC01894) is a non-coding RNA gene located on human chromosome 2, annotated and indexed in gene databases[1]. Like other lincRNAs, it is a RNA transcript greater than 200 nucleotides in length, not overlapping any protein-coding region, and does not encode a protein product. The majority of functional research for lincRNAs centers on their roles in gene expression regulation, chromatin modification, RNA stabilization, and sometimes enhancer activity, but LINC01894’s specific biological and clinical importance has not been defined. There is no evidence LINC01894 serves as a therapeutic drug target, nor is it currently used as a biomarker, and its molecular function and disease associations remain to be experimentally characterized[1][5]. LINC01894 is best classified as a human long intergenic non-coding RNA gene, not a protein, receptor, or traditional drug target. Its biological and pathological significance is presently unclear due to limited characterization in the scientific literature[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1894 (LINC01894).